ReShape Lifesciences
Bookmark
ShareCopied to clipboardReShape Lifesciences is a company. It is a public company in Irvine, the United States. It was founded in 2002 and its current CEO is Paul F. Hickey. It is part of the Health Care sector, specifically in the Health Care Equipment & Supplies industry.
Key facts
- city: Irvine
- country: United States
- employees: 29 people
- revenues: 8.2M $
- company type: public
- sector: Health Care
- industry: Health Care Equipment & Supplies
- foundation year: 2002
- CEO: Paul F. Hickey
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about ReShape Lifesciences:
Dataset of stocks from ReShape Lifesciences:
ReShape Lifesciences is one of the companies in the United States, companies in Health Care Equipment & Supplies, companies in Health Care, companies in Irvine and 3,456,808 companies in our database.
Talking Points
- ReShape Lifesciences | Transformative Devices for Obesity Treatment
- ReShape Lifesciences, Inc. is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. Our current portfolio includes the LAP-BAND® Adjustable Gastric Banding System and the ReShape Vest.
- ReShape Lifesciences Inc. (OTC:RSLS) is a premier weight-loss company, offering solutions to treat obesity and metabolic diseases.
- America's premier weight-loss and metabolic health-solutions company. | ReShape Lifesciences Inc. is America's premier weight-loss and metabolic health-solutions company, offering an integrated approach to managing and treating obesity. The FDA-approved Lap-Band® program provides minimally invasive, long-term treatment of obesity ...
- ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
- ReShape Gastric Vest | ReShape Lifesciences, Inc.
- The ReShape Vest™ is a revolutionary, anatomy-friendly, laparoscopic, implantable device to enable weight loss and stomach preservation. The procedure restricts stomach volume without cutting, stapling, or removing the stomach. Clinical Trials for the ReShape gastric vest are planned to begin in 2018.
- Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize treatment of chronic disease.